Takahiro Tsushima
Cleveland, OHNPI 1124541750
Payments from drug & device makers
What this record shows
This record is dominated by grants: $101,500 of the $152,130 with a category attached, or 66.7%. 22 manufacturers reported payments, led by Abbott at 39.5% of the total. Reporting peaked in 2023 at $67,890 and has fallen 66.8% since, to $22,527 in 2025.
Across 406 payments — averaging $374.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$60K
- Medtronic$42K
- Boston Scientific$36K
- Medical Device Business Services, Inc.$5K
- Biosense Webster, Inc.$5K
- Biotronik Inc.$3K
- plus $1K from 16 others
What the payments were for
- Grants$101,50067%
- Travel & lodging$35,27723%
- Food & beverage$14,2899%
- Education$1,0641%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 132 | $60,057 |
| Medtronic | 107 | $42,454 |
| Boston Scientific | 27 | $36,439 |
| Medical Device Business Services, Inc. | 39 | $4,873 |
| Biosense Webster, Inc. | 27 | $4,564 |
| Biotronik Inc. | 10 | $2,576 |
| Pfizer | 20 | $271 |
| Philips North America LLC | 7 | $239 |
| Atricure, Inc. | 7 | $122 |
| Amgen | 7 | $101 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $90 |
| Gilead | 3 | $54 |
| AstraZeneca(2 entities) | 2 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Novo Nordisk | 2 | $38 |
| Esperion Therapeutics, Inc. | 1 | $38 |
| Sanofi | 2 | $37 |
| Merck | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Lantheus Medical Imaging, Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$11,250
- ASSURITY$11,250
- Carto 3$8,169
- ENSITE PRECISION$5,006
- Micra$2,854
- AVEIR$1,913
- ENSITE$1,890
- GENERAL EP$1,863
- GALLANT$1,703
- EVERA MRI XT DR SURESCAN$1,698
- Solia$899
- Edora 8 DR-T$899
- Rivacor 7 DR-T$899
- Acticor 7 VR-T DX$899
- VersaCross Access Solution$694
- BioMonitor$505
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$466
- CAPSUREFIX NOVUS MRI SURESCAN$141
- SelectSecure$125
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 39 | $279 |
| Cephalexin | 14 | $137 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.